Aim: To screen and identify the potential biomarkers co-existing in plasma and serum of patients with non-small-cell lung cancer (NSCLC), and establish appropriate diagnostic models. Methods
Supplementary Figure S1 to S7 for manuscript (Exploration of a novel prognostic nomogram and diagnostic biomarkers based on the activity variations of hallmark gene sets in hepatocellular carcinoma).
Abbreviations: HR, hazard ratio, and other abbreviations and definitions as listed in Table 1.aAdjusted for age, gender, BMI, diabetic status, CCI, hemoglobin, serum albumin, hs-CRP, and PDV/BSA.bNumb